1. Home
  2. AERT vs MBRX Comparison

AERT vs MBRX Comparison

Compare AERT & MBRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aeries Technology Inc.

AERT

Aeries Technology Inc.

HOLD

Current Price

$0.56

Market Cap

27.9M

ML Signal

HOLD

Logo Moleculin Biotech Inc.

MBRX

Moleculin Biotech Inc.

HOLD

Current Price

$6.99

Market Cap

23.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AERT
MBRX
Founded
2012
2015
Country
Singapore
United States
Employees
N/A
N/A
Industry
Professional Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
27.9M
23.5M
IPO Year
N/A
2016

Fundamental Metrics

Financial Performance
Metric
AERT
MBRX
Price
$0.56
$6.99
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$125.00
AVG Volume (30 Days)
181.3K
140.6K
Earning Date
11-10-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$69,346,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.46
$6.01
52 Week High
$2.67
$91.25

Technical Indicators

Market Signals
Indicator
AERT
MBRX
Relative Strength Index (RSI) 46.39 86.29
Support Level $0.53 $6.88
Resistance Level $0.65 $7.98
Average True Range (ATR) 0.06 0.42
MACD 0.00 0.64
Stochastic Oscillator 44.29 87.50

Price Performance

Historical Comparison
AERT
MBRX

About AERT Aeries Technology Inc.

Aeries Technology Inc is a professional and management services partner offering a range of management consultancy services for private equity sponsors and their portfolio companies with engagement models that are designed to provide a mix of deep vertical specialty, functional expertise, and digital systems and solutions to scale, optimize and transform a client's business operations. It supports and drives its client's growth across the globe by providing a range of management consultancy services involving professional advisory services and operations management services to build and manage dedicated delivery centers in appropriate locations based on customer business needs.

About MBRX Moleculin Biotech Inc.

Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.

Share on Social Networks: